Research Yields Clues to Recurrent Prostate Cancer

[Guest guest]

From US News and World Report " According to the researchers, Stat5 is more likely to be active if

patients are treated with androgen deprivation therapy. The protein

interacts with the hormone receptors and keeps them active.

The researchers plan to test the dynamic between Stat5 and androgen

receptors using animal models to find out if the relationship produces

androgen-independent prostate tumor growth. " -- Emersonwww.flhw.org